본문 바로가기
KERD
논문KCI 등재

Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers

Ather Muneer
대한신경정신의학회 (Korean Neuropsychiatric Association)|2016.01|PSYCHIATRY INVESTIGATION|제13권 제1호|pp. 18-33|DOI http://dx.doi.org/10.4306/pi.2016.13.1.18

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

Bipolar disorderInflammationCytokinesBiomarkersNeurotrophins.
주제분류정신과학

초록

Bipolar disorder is a severe and enduring psychiatric condition which in many cases starts during early adulthood and follows a relapsing and remitting course throughout life. In many patients the disease follows a progressive path with brief periods of inter-episode recovery, sub-threshold symptoms, treatment resistance and increasing functional impairment in the biopsychosocial domains. Knowledge about the neurobiology of bipolar disorder is increasing steadily and evidence from several lines of research implicates immuno-inflammatory mechanisms in the brain and periphery in the etiopathogenesis of this illness and its comorbidities. The main findings are an increase in the levels of proinflammatory cytokines during acute episodes with a decrease in neurotrophic support. Related to these factors are glial cell dysfunction, neuro-endocrine abnormalities and neurotransmitter aberrations which together cause plastic changes in the mood regulating areas of the brain and neuroprogression of the bipolar diathesis. Research in the above mentioned areas is providing an opportunity to discover novel biomarkers for the disease and the field is reaching a point where major breakthroughs can be expected in the not too distant future. It is hoped that with new discoveries fresh avenues will be found to better treat an otherwise recalcitrant disease.

Abstract

Bipolar disorder is a severe and enduring psychiatric condition which in many cases starts during early adulthood and follows a relapsing and remitting course throughout life. In many patients the disease follows a progressive path with brief periods of inter-episode recovery, sub-threshold symptoms, treatment resistance and increasing functional impairment in the biopsychosocial domains. Knowledge about the neurobiology of bipolar disorder is increasing steadily and evidence from several lines of research implicates immuno-inflammatory mechanisms in the brain and periphery in the etiopathogenesis of this illness and its comorbidities. The main findings are an increase in the levels of proinflammatory cytokines during acute episodes with a decrease in neurotrophic support. Related to these factors are glial cell dysfunction, neuro-endocrine abnormalities and neurotransmitter aberrations which together cause plastic changes in the mood regulating areas of the brain and neuroprogression of the bipolar diathesis. Research in the above mentioned areas is providing an opportunity to discover novel biomarkers for the disease and the field is reaching a point where major breakthroughs can be expected in the not too distant future. It is hoped that with new discoveries fresh avenues will be found to better treat an otherwise recalcitrant disease.

참고문헌 (105)

  1. Fagiolini A, "Prevalence, chronicity, burden and borders of bipolar disorder", J Affect Disord, 148, pp.161~169 (2013)
  2. Vieta E, "Staging bipolar disorder", Neurotox Res, 19, pp.279~285 (2011)
  3. Uher R, "Gene-environment interactions in severe mental illness", Front Psychiatry, 5, pp.48~ (2014)
  4. Laursen TM, "Life expectancy among persons with schizophrenia or bipolar affective disorder", Schizophr Res, 131, pp.101~104 (2011)
  5. Hamdani N, "Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications", Curr Psychiatry Rep, 15, pp.387~ (2013)
  6. Gama CS, "Staging and neuroprogression in bipolar disorder : a systematic review of the literature", Rev Bras Psiquiatr, 35, pp.70~74 (2013)
  7. Bai YM, "Comparison of inflammatory cytokines levels among type I", type II and manic, euthymic, pp.depressive states of bipolar disorder, J Affect Disord[DOI]
  8. Stertz L, "Is bipolar disorder an inflammatory condition? The relevance of microglia activation", Curr Opin Psychiatry, 26, pp.19~26 (2013)
  9. Watkins CC, "Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application", Transl Psychiatry, 4, pp.e350~ (2014)
  10. Brietzke E, "Cytokines in bipolar disorder: recent findings, deleterious effects but promise for future therapeutics", CNS Spectr, 16, pp.157~168 (2011)
  11. Bai YM, "Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls", Bipolar Disord, 17, pp.269~277 (2015)
  12. Brambilla P, "Increased M1", decreased M2 signature and signs of Th1, Transl Psychiatry, pp.2014, 4[DOI]
  13. Barbosa IG, "A preliminary report of increased plasma levels of IL-33 in bipolar disorder : further evidence of pro-inflammatory status", J Affect Disord, 157, pp.41~44 (2014)
  14. Doganavsargil-Baysal O, "Levels of TNF-alpha, soluble TNF receptors (sTNF-R1, sTNF-R2) and cognition in bipolar disorder", Hum Psychopharmacol, 28, pp.160~167 (2013)
  15. Hope S, "Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder", Schizophr Res, 145, pp.36~42 (2013)
  16. Remlinger-Molenda A, "Activity of selected cytokines in bipolar patients during manic and depressive episodes", Psychiatr Pol, 46, pp.599~611 (2012)
  17. Remlinger-Molenda A, "Selected cytokine profile during remission in bipolar patients", Neuropsychobiology, 66, pp.193~198 (2012)
  18. Kunz M, "Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance", Rev Bras Psiquiatr, 33, pp.268~274 (2011)
  19. Hope S, "Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorder but not in schizophrenia", J Psychiatr Res, 45, pp.1608~1616 (2011)
  20. Guloksuz S, "Cytokine levels in euthymic bipolar patients", J Affect Disord, 126, pp.458~462 (2010)
  21. Barbosa IG, "Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder", Eur Arch Psychiatry Clin Neurosci, 261, pp.139~143 (2011)
  22. Hope S, "Similar immune profile in bipolar disorder and schizophrenia : selective increase in soluble tumor necrosis factor receptor I and von Willibrand factor", Bipolar Disord, 11, pp.726~734 (2009)
  23. Brietzke E, "Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder", J Affect Disord, 116, pp.214~217 (2009)
  24. Ortiz-Dominguez A, "Immune variations in bipolar disorder : phasic differences", Bipolar Disord, 9, pp.596~602 (2007)
  25. Kim YK, "Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder", J Affect Disord, 104, pp.91~95 (2007)
  26. O’Brien SM, "Cytokine profiles in bipolar affective disorder : focus on acutely ill patients", J Affect Disord, 90, pp.263~267 (2006)
  27. Kim YK, "T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients", Psychiatry Res, 129, pp.267~272 (2004)
  28. Su KP, "Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission", J Affect Disord, 71, pp.205~209 (2002)
  29. Tsai SY, "Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania", J Affect Disord, 64, pp.185~193 (2001)
  30. Munkholm K, "Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis", J Psychiatr Res, 47, pp.1119~1133 (2013)
  31. Prasad R, "Cerebrospinal fluid TNF-alpha, IL-6, and IL-8 in children with bacterial meningitis", Pediatr Neurol, 50, pp.60~65 (2014)
  32. Kontoangelos K, "Cytokines, diabetes mellitus and psychopathology: a challenging combination", Neuro Endocrinol Lett, 35, pp.159~169 (2014)
  33. Crump C, "Comorbidities and mortality in bipolar disorder : a Swedish national cohort study", JAMA Psychiatry, 70, pp.931~939 (2013)
  34. Goldstein BI, "Inflammation and the phenomenology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature", J Clin Psychiatry, 70, pp.1078~1090 (2009)
  35. Janelidze S, "Cytokine levels in blood may distinguish suicide attempters from depressed patients", Brain Behav Immun, 25, pp.335~339 (2011)
  36. Soderlund J, "Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder", J Psychiatry Neurosci, 36, pp.114~118 (2011)
  37. Maletic V, "Integrated neurobiology of bipolar disorder", Front Psychiatry, 5, pp.98~ (2014)
  38. Myint AM, "Kynurenines : from the perspective of major psychiatric disorders", FEBS J, 279, pp.1375~1385 (2012)
  39. 전찬수, "Disturbance of the Glutamatergic System in Mood Disorders", Experimental Neurobiology, 23(1), pp.28~35 (2014), 한국뇌신경과학회
  40. Park KM, "Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction", Cell Signal, 22, pp.977~983 (2010)
  41. Felger JC, "Cytokine effects on the basal ganglia and dopamine function : the subcortical source of inflammatory malaise", Front Neuroendocrinol, 33, pp.315~327 (2012)
  42. Lindqvist D, "Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity", Biol Psychiatry, 66, pp.287~292 (2009)
  43. Iria Grande, "The Role of BDNF as a Mediator of Neuroplasticity in Bipolar Disorder", PSYCHIATRY INVESTIGATION, 7(4), pp.243~250 (2010), 대한신경정신의학회
  44. Deltheil T, "Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice", Neuropharmacology, 55, pp.1006~1014 (2008)
  45. Patas K, "Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features", Brain Behav Immun, 36, pp.71~79 (2014)
  46. Parkhurst CN, "Microglia promote learning-dependant synapse formation through brain-derived neurotrophic factor", Cell, 155, pp.1596~1609 (2013)
  47. Yang J, "proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus", Cell Rep, 7, pp.796~806 (2014)
  48. Cunha AB, "Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes", Neurosci Lett, 398, pp.215~219 (2006)
  49. Berk M, "Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors", Neurosci Biobehav Rev, 35, pp.804~817 (2011)
  50. Soares JC, "Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder", Int J Neuropsychopharmacol, 6, pp.171~180 (2003)
  51. Maripuu M, "Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study", PLoS One, 9, pp.e98682~ (2014)
  52. Drevets WC, "Brain structural and functional abnormalities in mood disorders : implications for neurocircuitry models of depression", Brain Struct Funct, 213, pp.93~118 (2008)
  53. Pace TW, "Cytokine-effects on glucocorticoid receptor function : relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression", Brain Behav Immun, 21, pp.9~19 (2007)
  54. Havermans R, "Patterns of salivary cortisol secretion and responses to daily events in patients with remitted bipolar disorder", Psychoneuroendocrinology, 36, pp.258~265 (2011)
  55. Kamali M, "Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar disorder", J Affect Disord, 136, pp.350~358 (2012)
  56. Grossman F, "Catecholamines in depression : a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH", Psychiatry Res, 87, pp.21~27 (1999)
  57. Latalova K, "Autonomic nervous system in euthymic patients with bipolar affective disorder", Neuro Endocrinol Lett, 31, pp.829~836 (2010)
  58. Taylor V, "Associations between bipolar disorder and metabolic syndrome : a review", J Clin Psychiatry, 67, pp.1034~1041 (2006)
  59. Laursen TM, "Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries", PLoS One, 8, pp.e67133~ (2013)
  60. Schroeter ML, "Mood disorders are glial disorders : evidence from in vivo studies", Cardiovasc Psychiatry Neurol, 2010, pp.780645~ (2010)
  61. Rajkowska G, "Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder", Biol Psychiatry, 49, pp.741~752 (2001)
  62. Bowley MP, "Low glial numbers in the amygdala in major depressive disorder", Biol Psychiatry, 52, pp.404~412 (2002)
  63. Uranova NA, "Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders : a study from the Stanley Neuropathology Consortium", Schizophr Res, 67, pp.269~275 (2004)
  64. Gos T, "S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression : a postmortem study", J Psychiatr Res, 47, pp.1694~1699 (2013)
  65. Vostrikov VM, "Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders", Schizophr Res, 94, pp.273~280 (2007)
  66. Steiner J, "Immunological aspects in the neurobiology of suicide : elevated microglial density in schizophrenia and depression is associated with suicide", J Psychiatr Res, 42, pp.151~157 (2008)
  67. Harrison PJ, "The neuropathology of primary mood disorder", Brain, 125, pp.1428~1449 (2002)
  68. Rajkowaska G, "Cell pathology in mood disorders", Semin Clin Psychiatry, 7, pp.281~292 (2002)
  69. Ongur D, "Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania", Biol Psychiatry, 64, pp.718~726 (2008)
  70. Hashimoto K, "Increased levels of glutamate in brains from patients with mood disorders", Biol Psychiatry, 62, pp.1310~1316 (2007)
  71. Yuksel C, "Magnetic resonance spectroscopic studies of glutamate-related abnormalities in mood disorders", Biol Psychiatry, 68, pp.785~794 (2010)
  72. Chitty KM, "A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder", Eur Neuropsychopharmacol, 23, pp.1348~1363 (2013)
  73. Colla M, "Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol", Mol Psychiatry, 14, pp.696~704 (2009)
  74. Scumpia PO, "Alpha-lipoic acid effects on glial functions accompanying double-stranded RNA antiviral and inflammatory signaling", Neurochem Int, 64, pp.55~63 (2014)
  75. Wang P, "Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP", protein kinase A- and phosphatidylinositol 3-kinase-dependant NF-kappaB activation, 2010, pp.298, C1445~C1456
  76. Lee HN, "Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders", Biochem Pharmacol, 84, pp.1340~1350 (2012)
  77. Nahman S, "Effects of lithium on lipopolysacchride-induced inflammation in rat primary glial cells", Innate Immun, 18, pp.447~458 (2012)
  78. Kang K, "Lithium pretreatment reduces brain injury after intracerebral hemorrhage in rats", Neurol Res, 34, pp.447~454 (2012)
  79. Zhang Z, "Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats", Neuroscience, 221, pp.140~150 (2012)
  80. Sublette ME, "Meta-analysis of the effects of eicosapentaenoic acid(EPA)in clinical trials in depression", J Clin Psychiatry, 72, pp.1577~1584 (2011)
  81. Sarris J, "Omega-3 for bipolar disorder : meta-analyses of use in mania and bipolar depression", J Clin Psychiatry, 73, pp.81~86 (2012)
  82. Savitz J, "Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomized, double-blind, placebo-controlled, 2x2 clinical trial", BMJ Open, 2, pp.e000643~ (2012)
  83. Berk M, "Aspirin : a review of its neurobiological properties and therapeutic potential for mental illness", BMC Med, 11, pp.74~ (2013)
  84. Nery FG, "Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study", Hum Psychopharmacol, 23, pp.87~94 (2008)
  85. Hlatky MA, "Criteria for evaluation of novel markers of cardiovascular risk : a scientific statement from the American Heart Association", Circulation, 119, pp.2408~2416 (2009)
  86. Munkholm K, "Cytokines in bipolar disorder : a systematic review and meta-analysis", J Affect Disord, 144, pp.16~27 (2013)
  87. Modabbernia A, "Cytokine alterations in bipolar disorder : a meta-analysis of 30 studies", Biol Psychiatry, 74, pp.15~25 (2013)
  88. Klein AB, "Blood BDNF concentrations reflect brain-tissue BDNF levels across species", Int J Neuropsychopharmacol, 14, pp.347~353 (2011)
  89. Geller B, "Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype", Am J Psychiatry, 161, pp.1698~1700 (2004)
  90. Lin PY, "State-dependant decrease in levels of brain-derived neurotrophic factor in bipolar disorder : a meta-analytic study", Neurosci Lett, 466, pp.139~143 (2009)
  91. Munkholm K, "Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients", Psychoneuroendocrinology, 47, pp.199~211 (2014)
  92. Machado-Vieira R, "Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode", Biol Psychiatry, 61, pp.142~144 (2007)
  93. Fernandes BS, "Serum brain-derived neurotrophic factor in bipolar and unipolar depression : a potential adjunctive tool for differential diagnosis", J Psychiatr Res, 43, pp.1200~1204 (2009)
  94. Fernandes BS, "Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders : a systematic review and meta-regression analysis", J Psychiatr Res, 45, pp.995~1004 (2011)
  95. Palomino A, "Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients", Schizophr Res, 86, pp.321~322 (2006)
  96. Grande I, "Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes : an open-label trial in drug-free patients with bipolar disorder", J Psychiatr Res, 46, pp.1511~1514 (2012)
  97. de Sousa RT, "Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania : a preliminary 4 week study", Neurosci Lett, 494, pp.54~56 (2011)
  98. Dowlati Y, "A meta-analysis of cytokines in major depression", Biol Psychiatry, 67, pp.446~457 (2010)
  99. Liu Y, "Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression", J Affect Disord, 139, pp.230~239 (2012)
  100. Hannestad J, "The effect of antidepressant medication treatment on serum levels of inflammatory cytokines : a meta-analysis", Neurophychopharmacology, 36, pp.2452~2459 (2011)
  101. Young JJ, "A review of the relationship between proinflammatory cytokines and major depressive disorder", J Affect Disord, 169, pp.15~20 (2014)
  102. Bai YM, "Pro-inflammatory cytokines associated with somatic and pain symptoms in depression", J Affect Disord, 155, pp.28~34 (2014)
  103. O’Donovan A, "Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder", Depress Anxiety, 30, pp.307~314 (2013)
  104. Warner-Schmidt JL, "Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior", Proc Natl Acad Sci U S A, 109, pp.11360~11365 (2012)
  105. Anisman H, "Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects", J Psychiatry Neurosci, 33, pp.131~141 (2008)

관련 논문AI추천

Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers박성우, 박원명, 이정구, Dae-Hyun Seog, Mi Kyoung Seo, Young Sup Woo대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제2호Neuroinflammation, Gut-Brain Axis and DepressionAlper Evrensel, Barıs¸ Önen Ünsalver, Mehmet Emin Ceylan대한신경정신의학회 · PSYCHIATRY INVESTIGATION2020 · 제17권 제1호The Staging of Major Mood Disorders: Clinical and Neurobiological CorrelatesAther Muneer, Rana Mazommil대한신경정신의학회 · PSYCHIATRY INVESTIGATION2018 · 제15권 제8호Depression and Mania Induce Pro-inflammatory Activation of Macrophages Following Application of Serum from Individuals with Bipolar DisorderAdriane Ribeiro Rosa, Bruna Maria Ascoli, Fábio Klamt, Fátima T.C.R. Guma, Flávio Kapczinski, Florencia M. Barbé-Tuana, Gabriel Fries, Luiza Paul Géa, Márcia Kauer-Sant’anna, Mariana Migliorini Parisi, Matheus Becker, Pamela Ferrari, Rafael Colombo대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2018 · 제16권 제1호The Neuroimmunology of SchizophreniaAnnya M. Smyth, Stephen M. Lawrie대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2013 · 제11권 제3호Biomarkers of Major Depressive Disorder: Knowing is Half the BattleAkriti Dangol, Govind Arora, Ravinder Singh, Sahil Malik, Sanjay Goyal대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제1호

이 간행물의 다른 논문 (9건)

Three Large-Scale Functional Brain Networks from Resting-State Functional MRI in Subjects with Different Levels of Cognitive Impairment이창욱, 주수현, 임현국pp. 1-7Induced Pluripotent Stem Cells as a Novel Tool in Psychiatric Research김세웅, 김보라, 이상혁, 김민경, 오대영pp. 8-17Perspectives on the Happiness of Community-Dwelling Elderly in Korea전상원, 김승현, 고영훈, 조숙행, 배치운, 정현강, David C. Steffens, Jongha Lee, JaeHyoung Lim, 한창수, 박문호pp. 50-57Insomnia in North Korean Refugees: Association with Depression and Post-Traumatic Stress SymptomsSo Young Yu, So Hee Lee, Ju Hyun Park, Soo Hyun Kim, 김석주, 이유진, Yu-Jin Lee, Jin Yong Junpp. 67-73Copycat Suicide Induced by Entertainment Celebrity Suicides in South Korea장수아, 전우택, 성지민, 박진영pp. 74-81
원문 보기